Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
4.9K
The Ras Gene02:38

The Ras Gene

6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Experimental RNAi02:15

Experimental RNAi

6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Types of RNA01:23

Types of RNA

63.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A synergistic multi-omics approach: causal sepsis drivers identified in activated CD4<sup>+</sup> T cells by single-cell RNA sequencing and Mendelian randomization.

Frontiers in cellular and infection microbiology·2026
Same author

Facilitators and Barriers to Voice Prosthesis Rehabilitation After Total Laryngectomy: A Qualitative Study Using the COM-B Model.

Journal of voice : official journal of the Voice Foundation·2026
Same author

Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia.

Cancer medicine·2026
Same author

Polatuzumab vedotin-R-CHP used for high-risk EBV-negative DLBCL-type post-transplant lymphoproliferative disorder in a long-term kidney transplant recipient: a case report.

Frontiers in oncology·2026
Same author

PA-X 122V broadly determines the host shutoff activity of influenza A viruses.

mBio·2025
Same author

Azacitidine as maintenance therapy in pediatric <i>de novo</i> acute myeloid leukemia.

Frontiers in immunology·2025

Related Experiment Video

Updated: May 29, 2025

Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.1K

Circular RNAs in cancer.

Yang Guo1, Qiang Huang1, Yu Heng1

  • 1ENT Institute and Department of Otorhinolaryngology Eye & ENT Hospital, Fudan University Xuhui District Shanghai China.

Medcomm
|February 4, 2025
PubMed
Summary
This summary is machine-generated.

Circular RNAs (circRNAs) are key in cancer, regulating its hallmarks. Further research into circRNA's role in thyroid cancer (TC) resistance to chemoradiotherapy is crucial for developing new treatments.

Keywords:
biomarkercircular RNAhallmarks of cancertherapeutic targetsthyroid cancer

More Related Videos

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.5K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs
13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

7.3K

Related Experiment Videos

Last Updated: May 29, 2025

Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.1K
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.5K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs
13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

7.3K

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are noncoding RNAs with a unique structure.
  • They play roles in physiological and pathological processes, including cancer.
  • Their specific functions in chemoradiotherapy resistance and clinical applications are not fully understood.

Purpose of the Study:

  • To provide a comprehensive overview of circRNAs.
  • To summarize circRNA involvement in cancer hallmarks.
  • To highlight circRNAs' potential as biomarkers and therapeutic targets in thyroid cancer (TC).

Main Methods:

  • Literature review of circRNA biogenesis, characteristics, functions, and turnover.
  • Analysis of circRNA roles in cancer hallmarks.
  • Focus on circRNAs in thyroid cancer (TC) and chemoradiotherapy resistance.

Main Results:

  • CircRNAs are involved in cancer hallmarks through various mechanisms.
  • Their potential as biomarkers and therapeutic targets is significant.
  • The "Ying-Yang" dynamic regulation of circRNAs in TC requires further investigation.

Conclusions:

  • CircRNAs have diverse roles in cancer development and progression.
  • CircRNAs show promise as biomarkers and therapeutic targets, particularly in thyroid cancer.
  • More research is needed to explore circRNA functions in chemoradiotherapy resistance and clinical applications.